90 related articles for article (PubMed ID: 34197749)
21. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis.
Belkouz A; Labeur TA; Dierks J; Dijk F; van Oijen MGH; Verheij J; van Gulik TM; van de Vijver MJ; Wilmink H; Punt CJA; Klümpen HJ
Crit Rev Oncol Hematol; 2019 Sep; 141():82-94. PubMed ID: 31255992
[TBL] [Abstract][Full Text] [Related]
22. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.
Lim JY; Jeung HC; Mun HS; Lee DK; Paik YH; Lee SJ; Yoon DS; Cho JY
Anticancer Drugs; 2008 Jul; 19(6):631-5. PubMed ID: 18525323
[TBL] [Abstract][Full Text] [Related]
24. Equipoise, drug development, and biliary cancer.
Lee TY; Bates SE; Abou-Alfa GK
Cancer; 2022 Mar; 128(5):944-949. PubMed ID: 34817855
[No Abstract] [Full Text] [Related]
25. Advances in the treatment of biliary tract cancers.
Uson Junior PLS; Bogenberger J; Borad MJ
Curr Opin Gastroenterol; 2020 Mar; 36(2):85-89. PubMed ID: 31972599
[TBL] [Abstract][Full Text] [Related]
26. Combined chemotherapy of irinotecan and low-dose cisplatin (I/low-P) against metastatic biliary tract cancer.
Sugita H; Hirota M; Ichihara A; Furuhashi S; Kihara S; Shimada S
J Hepatobiliary Pancreat Surg; 2006; 13(5):463-7. PubMed ID: 17013724
[TBL] [Abstract][Full Text] [Related]
27. Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
Lowery MA; Goff LW; Keenan BP; Jordan E; Wang R; Bocobo AG; Chou JF; O'Reilly EM; Harding JJ; Kemeny N; Capanu M; Griffin AC; McGuire J; Venook AP; Abou-Alfa GK; Kelley RK
Cancer; 2019 Dec; 125(24):4426-4434. PubMed ID: 31454426
[TBL] [Abstract][Full Text] [Related]
28. Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer.
Colleoni M; Di Bartolomeo M; Di Leo A; Zilembo N; Carnaghi C; Pandolfi A; Rimassa L; Artale S; Bajetta E
Eur J Cancer; 1995 Dec; 31A(13-14):2426-7. PubMed ID: 8652289
[No Abstract] [Full Text] [Related]
29. Second-line therapies in advanced biliary tract cancers.
Tella SH; Kommalapati A; Borad MJ; Mahipal A
Lancet Oncol; 2020 Jan; 21(1):e29-e41. PubMed ID: 31908303
[TBL] [Abstract][Full Text] [Related]
30. A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
Ciuleanu T; Diculescu M; Hoepffner NM; Trojan J; Sailer V; Zalupski M; Herrmann T; Roth A; Chick J; Brock K; Albert D; Philip PA
Invest New Drugs; 2007 Aug; 25(4):385-90. PubMed ID: 17364234
[TBL] [Abstract][Full Text] [Related]
31. Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas.
Chen JS; Jan YY; Lin YC; Wang HM; Chang WC; Liau CT
Anticancer Drugs; 1998 Jun; 9(5):393-7. PubMed ID: 9660535
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.
Kim BJ; Yoo C; Kim KP; Hyung J; Park SJ; Ryoo BY; Chang HM
Br J Cancer; 2017 Feb; 116(5):561-567. PubMed ID: 28081540
[TBL] [Abstract][Full Text] [Related]
33. Second-line chemotherapy in advanced biliary cancer: the present now will later be past.
Vivaldi C; Fornaro L; Cereda S; Aprile G; Santini D; Silvestris N; Lonardi S; Leone F; Milella M; Brandi G; Vasile E
Ann Oncol; 2014 Dec; 25(12):2443-2444. PubMed ID: 25122694
[No Abstract] [Full Text] [Related]
34. [Biliary tract diseases. Gallbladder and biliary duct cancer].
Vilatobá Chapa M
Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():199-201. PubMed ID: 20959250
[No Abstract] [Full Text] [Related]
35. [Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/ leucovorin (FOLFOX-4 chemotherapy)].
Garrido M; Melgoza G; Galindo H; Madrid J; Sánchez C; Nervi B; Alvarez M; Orellana E
Rev Med Chil; 2007 Nov; 135(11):1380-7. PubMed ID: 18259648
[TBL] [Abstract][Full Text] [Related]
36. [Adenomatous polyp of the common bile duct; benign tumors of the bile ducts].
ALTHABE A; POGGI DA; FLACHSLAND SIBURU EH
Bol Trab Acad Argent Cir; 1949 Jul; 33(12):380-92. PubMed ID: 18139078
[No Abstract] [Full Text] [Related]
37. Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer.
Jung JH; Lee HS; Jo JH; Cho IR; Chung MJ; Bang S; Park SW; Song SY; Park JY
Chemotherapy; 2017; 62(6):361-366. PubMed ID: 28848173
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of biliary tract cancer with mitomycin-C and 5-fluorouracil biologically modulated by folinic acid. A phase II study.
Polyzos A; Nikou G; Giannopoulos A; Toskas A; Kalahanis N; Papargyriou J; Michail P; Papachristodoulou A
Ann Oncol; 1996 Aug; 7(6):644-5. PubMed ID: 8879384
[No Abstract] [Full Text] [Related]
39. Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
Nakachi K; Konishi M; Ikeda M; Shimada K; Okusaka T; Saiura A; Ishii H; Sugiyama M; Furuse J; Sakamoto H; Shimamura T; Ohta T
Int J Clin Oncol; 2018 Oct; 23(5):894-899. PubMed ID: 29705976
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
Sebbagh S; Roux J; Dreyer C; Neuzillet C; de Gramont A; Orbegoso C; Hentic O; Hammel P; de Gramont A; Raymond E; André T; Chibaudel B; Faivre S
Acta Oncol; 2016; 55(9-10):1168-1174. PubMed ID: 27333436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
